Patient-Provider Distance in Medicare Outpatient Oncology Telehealth Versus Office Visits, 2021‐2023: Cross-Sectional Claims Analysis - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Travel Distance Between Patients and Providers for Medicare Outpatient Oncology Telehealth and Office Visits, 2021–2023: A Cross-Sectional Claims Study

  • By

  • Lingbo Liu

  • Tracy Onega

  • Erika L Moen

  • Anna N A Tosteson

  • Rebecca E Smith

  • Qianfei Wang

  • Lauren Cowan

  • Fahui Wang

  • October 23, 2026

Share

Clinical Scorecard: Travel Distance Between Patients and Providers for Medicare Outpatient Oncology Telehealth and Office Visits, 2021–2023: A Cross-Sectional Claims Study

At a Glance

CategoryDetail
ConditionGeographic distance between patients and providers in outpatient oncology care
Key MechanismsTelehealth encounters were associated with modestly greater patient-provider distance, particularly at the upper end of the distance distribution; the measure represents geographic service reach, not travel for virtual visits.
Target PopulationTraditional Medicare fee-for-service beneficiaries aged 66 years or older receiving outpatient care for breast, colon, rectal, endometrial, lung, or prostate cancer during 2021–2023.
Care SettingMedicare outpatient oncology care, comparing telehealth with in-person office visits.

Key Highlights

  • Across rurality categories, median patient-provider distances were greater for telehealth than office visits, with differences of 0.9 to 3.2 miles.
  • Telehealth increased the distance encompassing 80% of visits (d80) by approximately 8 to 14 miles across rurality categories.
  • Telehealth and office-visit distance distributions remained closely aligned within every rurality stratum and Census region.
  • Median distances and dispersion increased as rurality increased for both encounter types.
  • The study measured straight-line geographic separation using beneficiary and provider ZIP-code centroids, not actual travel distance.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Assess whether telehealth reduces high-burden travel for patients most affected and whether benefits are distributed equitably, as proposed by the study authors.

      Risks

      • The study authors note that telehealth alone does not remove structural contributors to travel burden, including workforce maldistribution, regionalization of specialty services, and unequal digital infrastructure.
      • Telehealth access may depend on digital infrastructure, patient support, and regulatory circumstances, including cross-state care and licensure.

      Patient & Prescribing Data

      Traditional Medicare fee-for-service beneficiaries aged 66 years or older with outpatient care for breast, colon, rectal, endometrial, lung, or prostate cancer, 2021–2023.

      This claims study compared telehealth and office visits; it did not evaluate medication prescribing or treatment effectiveness. The authors describe telehealth as supplementing facility-based services that require physical presence.

      Clinical Best Practices

      • Interpret telehealth patient-provider distance as geographic service reach, not travel undertaken for the virtual encounter.
      • Consider that diagnosis, imaging, infusion, radiation, procedures, and surgery often continue to require in-person services, as described in the article.
      • When evaluating access, account for rurality and digital infrastructure, patient support, and regulatory circumstances.

      Related Resources & Content

        Original Source(s)

        Related Content